“I have been involved with the financial and economic aspects of commercial litigation since 1990 and have focused on intellectual property disputes since 1998.”Chicago Office
+1 312 327 4412
I have offered expert testimony in federal courts and in deposition on dozens of occasions.
Involved in Paragraph IV disputes since 2005
Experience with certain economic aspects of the U.S. pharmaceutical industry
Robert McSorley is a Senior Director in Ocean Tomo’s Expert Testimony practice, working out of the Chicago office. Mr. McSorley has 30 years of experience addressing the economic, financial, and accounting issues concerning commercial litigation. Mr. McSorley has focused on intellectual property disputes since 1998, and regularly evaluates the measures and amounts of monetary recovery for infringement/misappropriation. He has offered expert testimony in Federal Courts and in depositions on dozens of occasions, and courts and juries have adopted his opinions and conclusions.
Mr. McSorley is regularly retained by generic pharmaceutical firms (defendants) involved with Hatch-Waxman litigation. Mr. McSorley has been involved in Paragraph IV disputes since 2005. In connection with these engagements, Mr. McSorley evaluates financial and economic evidence relating to the issue of Commercial Success, a secondary indicium of non-obviousness. In addition, he regularly evaluates allegations of irreparable harm. Through his work in these engagements, Mr. McSorley has gained experience with certain economic aspects of the U.S. pharmaceutical industry, such as the profitability of the U.S. Fortune 500 pharmaceutical firms and their ability to finance and recover R&D costs.
Mr. McSorley holds a B.A. degree in Accounting from The Pennsylvania State University and a J.D. from the University of Pittsburgh. He is a CPA and a licensed Attorney. Mr. McSorley is a member of the Licensing Executive Society, the American Institute of Certified Public Accountants, and the Federal Circuit Bar Association.